Repurposing existing drugs will be a quicker way to tackle the coronavirus pandemic than developing a vaccine, scientists have argued.
In a paper published Thursday in the British Journal of Pharmacology, a team of international experts said that while there was no “magic bullet” for treating Covid-19, successfully identifying a drug for the virus was likely to take less time than rolling out a vaccine.
According to the paper, a vaccine which is both effective and scalable would likely take more than a year to reach the market, echoing previous assertions from biotech experts that developing a safe-to-use immunization will take between 12 and 18 months.